1. Cystic Fibrosis Transmembrane Conductance Regulator Modulators for Personalized Drug Treatment of Cystic Fibrosis

   • Frédéric Becq

   Leading Article 17 September 2012 Pages: 241 - 259

   

2. Rituximab for the Treatment of Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukaemia

   • Fredrick Hagemeister

   Review Article 17 September 2012 Pages: 261 - 272

   

3. Current and Emerging Treatment Strategies for Cutaneous T-cell Lymphoma

   • Frederick Lansigan
   • Francine M. Foss

   Review Article 17 September 2012 Pages: 273 - 286

   

4. Piracetam and Piracetam-Like Drugs

   • Andrei G. Malykh
   • M. Reza Sadaie

   Review Article 17 September 2012 Pages: 287 - 312

   

5. Infections with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae

   • Johann D. D. Pitout

   Review Article 17 September 2012 Pages: 313 - 333

   

6. Pharmacotherapy and Weight-Loss Supplements for Treatment of Paediatric Obesity

   • Alexander L. Rogovik
   • Jean-Pierre Chanoine
   • Ran D. Goldman

   Review Article 17 September 2012 Pages: 335 - 346

   

7. Triptorelin Embonate (6-Month Formulation)

   • Gillian M. Keating

   Adis Drug Profile 17 September 2012 Pages: 347 - 353

   

8. Trabectedin

   • Natalie J. Carter
   • Susan J. Keam

   Adis Drug Evaluation 17 September 2012 Pages: 355 - 376